Co-delivery of 5-fluorodeoxyuridine and doxorubicin via gold nanoparticle equipped with affibody-DNA hybrid strands for targeted synergistic chemotherapy of HER2 overexpressing breast cancer

Abstract Combination chemotherapy is still of great importance as part of the standard clinical care for patients with HER2 positive breast cancer. As an attractive component, gold nanoparticles (AuNPs) have been extensively studied as biosafety nanomaterials, but they are rarely explored as drug na...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Chao Zhang, Fanghua Zhang, Mengnan Han, Xuming Wang, Jie Du, Honglei Zhang, Wei Li
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2020
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/b6e9d52f75ba47d5b8150e1934cee510
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:b6e9d52f75ba47d5b8150e1934cee510
record_format	dspace
spelling	oai:doaj.org-article:b6e9d52f75ba47d5b8150e1934cee5102021-12-02T13:33:59ZCo-delivery of 5-fluorodeoxyuridine and doxorubicin via gold nanoparticle equipped with affibody-DNA hybrid strands for targeted synergistic chemotherapy of HER2 overexpressing breast cancer10.1038/s41598-020-79125-02045-2322https://doaj.org/article/b6e9d52f75ba47d5b8150e1934cee5102020-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-79125-0https://doaj.org/toc/2045-2322Abstract Combination chemotherapy is still of great importance as part of the standard clinical care for patients with HER2 positive breast cancer. As an attractive component, gold nanoparticles (AuNPs) have been extensively studied as biosafety nanomaterials, but they are rarely explored as drug nanocarriers for targeted co-delivery of multiple chemotherapeutics. Herein, a novel affibody-DNA hybrid strands modified AuNPs were fabricated for co-loading nucleoside analogue (5-fluorodeoxyuridine, FUdR) and anthracycline (doxorubicin, Dox). FUdRs were integrated into DNA hybrid strands decorated on AuNPs by DNA solid phase synthesis, and Dox molecules were intercalated into their duplex regions. Affibody molecules coupled to the DNA hybrid strands were distributed the surface of AuNPs, giving them targeting for HER2. The new dual-drug-containing affibody-DNA-AuNPs (Dox@affi-F/AuNPs) owned compact and stable spherical nanostructures, and precise drug loading. Cytotoxicity tests demonstrated that these nanoparticles caused a higher inhibition in HER2 overexpressing breast cancer cells, and showed better synergistic antitumor activity than simple mixture of the two drugs. The related mechanistic studies proved that Dox@affi-F/AuNPs achieved a remarkable combined antitumor activity of Dox and FUdR by promoting more cells to enter apoptosis pathway. Our work provided a nanomedicine platform for targeted co-delivery of nucleoside analog therapeutics and anthracycline anticancer drugs to achieve synergistic treatment of HER2+ cancer.Chao ZhangFanghua ZhangMengnan HanXuming WangJie DuHonglei ZhangWei LiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-14 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Chao Zhang Fanghua Zhang Mengnan Han Xuming Wang Jie Du Honglei Zhang Wei Li Co-delivery of 5-fluorodeoxyuridine and doxorubicin via gold nanoparticle equipped with affibody-DNA hybrid strands for targeted synergistic chemotherapy of HER2 overexpressing breast cancer
description	Abstract Combination chemotherapy is still of great importance as part of the standard clinical care for patients with HER2 positive breast cancer. As an attractive component, gold nanoparticles (AuNPs) have been extensively studied as biosafety nanomaterials, but they are rarely explored as drug nanocarriers for targeted co-delivery of multiple chemotherapeutics. Herein, a novel affibody-DNA hybrid strands modified AuNPs were fabricated for co-loading nucleoside analogue (5-fluorodeoxyuridine, FUdR) and anthracycline (doxorubicin, Dox). FUdRs were integrated into DNA hybrid strands decorated on AuNPs by DNA solid phase synthesis, and Dox molecules were intercalated into their duplex regions. Affibody molecules coupled to the DNA hybrid strands were distributed the surface of AuNPs, giving them targeting for HER2. The new dual-drug-containing affibody-DNA-AuNPs (Dox@affi-F/AuNPs) owned compact and stable spherical nanostructures, and precise drug loading. Cytotoxicity tests demonstrated that these nanoparticles caused a higher inhibition in HER2 overexpressing breast cancer cells, and showed better synergistic antitumor activity than simple mixture of the two drugs. The related mechanistic studies proved that Dox@affi-F/AuNPs achieved a remarkable combined antitumor activity of Dox and FUdR by promoting more cells to enter apoptosis pathway. Our work provided a nanomedicine platform for targeted co-delivery of nucleoside analog therapeutics and anthracycline anticancer drugs to achieve synergistic treatment of HER2+ cancer.
format	article
author	Chao Zhang Fanghua Zhang Mengnan Han Xuming Wang Jie Du Honglei Zhang Wei Li
author_facet	Chao Zhang Fanghua Zhang Mengnan Han Xuming Wang Jie Du Honglei Zhang Wei Li
author_sort	Chao Zhang
title	Co-delivery of 5-fluorodeoxyuridine and doxorubicin via gold nanoparticle equipped with affibody-DNA hybrid strands for targeted synergistic chemotherapy of HER2 overexpressing breast cancer
title_short	Co-delivery of 5-fluorodeoxyuridine and doxorubicin via gold nanoparticle equipped with affibody-DNA hybrid strands for targeted synergistic chemotherapy of HER2 overexpressing breast cancer
title_full	Co-delivery of 5-fluorodeoxyuridine and doxorubicin via gold nanoparticle equipped with affibody-DNA hybrid strands for targeted synergistic chemotherapy of HER2 overexpressing breast cancer
title_fullStr	Co-delivery of 5-fluorodeoxyuridine and doxorubicin via gold nanoparticle equipped with affibody-DNA hybrid strands for targeted synergistic chemotherapy of HER2 overexpressing breast cancer
title_full_unstemmed	Co-delivery of 5-fluorodeoxyuridine and doxorubicin via gold nanoparticle equipped with affibody-DNA hybrid strands for targeted synergistic chemotherapy of HER2 overexpressing breast cancer
title_sort	co-delivery of 5-fluorodeoxyuridine and doxorubicin via gold nanoparticle equipped with affibody-dna hybrid strands for targeted synergistic chemotherapy of her2 overexpressing breast cancer
publisher	Nature Portfolio
publishDate	2020
url	https://doaj.org/article/b6e9d52f75ba47d5b8150e1934cee510
work_keys_str_mv	AT chaozhang codeliveryof5fluorodeoxyuridineanddoxorubicinviagoldnanoparticleequippedwithaffibodydnahybridstrandsfortargetedsynergisticchemotherapyofher2overexpressingbreastcancer AT fanghuazhang codeliveryof5fluorodeoxyuridineanddoxorubicinviagoldnanoparticleequippedwithaffibodydnahybridstrandsfortargetedsynergisticchemotherapyofher2overexpressingbreastcancer AT mengnanhan codeliveryof5fluorodeoxyuridineanddoxorubicinviagoldnanoparticleequippedwithaffibodydnahybridstrandsfortargetedsynergisticchemotherapyofher2overexpressingbreastcancer AT xumingwang codeliveryof5fluorodeoxyuridineanddoxorubicinviagoldnanoparticleequippedwithaffibodydnahybridstrandsfortargetedsynergisticchemotherapyofher2overexpressingbreastcancer AT jiedu codeliveryof5fluorodeoxyuridineanddoxorubicinviagoldnanoparticleequippedwithaffibodydnahybridstrandsfortargetedsynergisticchemotherapyofher2overexpressingbreastcancer AT hongleizhang codeliveryof5fluorodeoxyuridineanddoxorubicinviagoldnanoparticleequippedwithaffibodydnahybridstrandsfortargetedsynergisticchemotherapyofher2overexpressingbreastcancer AT weili codeliveryof5fluorodeoxyuridineanddoxorubicinviagoldnanoparticleequippedwithaffibodydnahybridstrandsfortargetedsynergisticchemotherapyofher2overexpressingbreastcancer
_version_	1718392816737976320

Co-delivery of 5-fluorodeoxyuridine and doxorubicin via gold nanoparticle equipped with affibody-DNA hybrid strands for targeted synergistic chemotherapy of HER2 overexpressing breast cancer

Ejemplares similares